NCT Number: NCT02008838
Effects of Synbiotic Supplementation in Metabolic Syndrome
To evaluate the effects of synbiotic supplementation on insulin resistance, and lipid profile in subjects with metabolic syndrome, in a randomized, double-blind, placebo-controlled pilot study, 38 subjects with metabolic syndrome will be supplemented with either synbiotic or placebo capsules twice/day for 28 weeks. Both the synbiotic (G1) and the placebo (G2) groups will be advised to follow an energy balanced diet and physical activity recommendations. Parameters related to metabolic syndrome and insulin resistance will be measured every 7 weeks during the study course.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2 / Phase 3
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 18 years of age and older
- having three of the following five features: Increased waist circumference (≥102 cm in men and ≥88 cm in women), elevated TG (≥150 mg/dl), reduced HDL-C (≤40 mg/dl in men and ≤50 mg/dl in women), elevated blood pressure (≥130/85 mm Hg or on treatment for hypertension) and elevated glucose (≥100 mg/dl), according to the National Cholesterol Education Program Adult Treatment Panel III report
- BMI : 25≥ BMI ≥ 40
Exclusion criteria
- Use antibiotic 2 weeks before recruitment to the study
- A history of alcohol consumption
- Pregnancy & Breast feeding , Professional athelets
- A history of Cardiovascular disease, Pulmonary disease, Renal disease & Celiac disease
Treatment and study plan
Placebo
Dietary SupplementPrimary outcomes
-
HOMA-IR
Time frame: 28 weeks
Sponsors and collaborators
Lead sponsor
National Nutrition and Food Technology Institute
Other
Registry information
Important dates
- Study start
- 2012
- Primary completion
- 2012
- First posted
- Dec 11, 2013
- Registry last updated
- Dec 11, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Sleep Chatbot Intervention for Emerging Black/African American Adults
NCT05956886
Dyssomnias, Glucose Metabolism Disorders
Newark, Delaware, United States
View Trial DetailsEffects of Cornelian Cherry Supplementation in Patients With Metabolic Syndrome
NCT07739602
Glucose Metabolism Disorders, Hyperinsulinism
Wroclaw, Poland
View Trial DetailsThe Influence of Time-Restricted Eating in Patients With Metabolic Syndrome
NCT04057339
Behavior, Fasting
La Jolla, California, United States
View Trial DetailsModified Huanglian Wendan Decoction for Metabolic Syndrome
NCT07702669
Glucose Metabolism Disorders, Hyperinsulinism
Harbin, Heilongjiang, China
View Trial Details